Barriers to human papillomavirus vaccination among us adolescents a systematic review of the literature

JAMA Pediatrics

Volumn 168, Issue 1, 2014, Pages 76-82

  Holman, Dawn M ^a   Benard, Vicki ^a   Roland, Katherine B ^a   Watson, Meg ^a   Liddon, Nicole ^b   Stokley, Shannon ^c  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENCE; ADOLESCENT; ATTITUDE TO HEALTH; CAREGIVER; HEALTH CARE COST; HEALTH CARE PERSONNEL; HUMAN; INFECTION RISK; INFORMATION LITERACY; MEDICALLY UNDERSERVED; PAPILLOMAVIRUS INFECTION; PARENTAL ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; REVIEW; SEX DIFFERENCE; SEXUAL BEHAVIOR; SYSTEMATIC REVIEW; UNITED STATES; VACCINATION;

ADOLESCENT; ATTITUDE OF HEALTH PERSONNEL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTS; PATIENT ACCEPTANCE OF HEALTH CARE; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 84892750822     PISSN: 21686203     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapediatrics.2013.2752     Document Type: Review

References (84)

1. Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR. Prevalence of HPV infection among men. J Infect Dis. 2006;194(8):1044-1057.
2. Dunne EF, Sternberg M, Markowitz LE, et al. Human papillomavirus (HPV) 6, 11, 16, and 18 prevalence among females in the United States-National Health and Nutrition Examination Survey, 2003-2006: opportunity to measure HPV vaccine impact? J Infect Dis. 2011;204(4):562-565.
3. Centers for Disease Control and Prevention (CDC). Human papillomavirus-associated cancers: how many cancers are linked with HPV each year? http://www.cdc.gov/cancer/hpv/statistics/cases.htm. Accessed October 18, 2013.
4. IARCWorking Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum. 2007;90:1-636.
5. Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer. 2008;113(10)(suppl):3036-3046.
6. Hariri S, Unger er, Sternberg M, et al. Prevalence of genital human papillomavirus among females in the United States, the National Health and Nutrition Examination Survey, 2003-2006. J Infect Dis. 2011;204(4):566-573.
7. Centers for Disease Control and Prevention (CDC). National and state vaccination coverage among adolescents aged 13 through 17 years-United States, 2010. MMWR Morb Mortal Wkly Rep. 2011;60(33):1117-1123.
8. Centers for Disease Control and Prevention (CDC). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010;59(20):626-629.
9. Centers for Disease Control and Prevention (CDC). Recommendations on the use of quadrivalent human papillomavirus vaccine in males-Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011;60(50):1705-1708.
10. US Department of Health and Human Services. Immunization and Infectious Diseases. Healthy People 2020 Topics & Objectives May 18, 2012. http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx? topicid=23. Accessed May 29, 2012.
11. Centers for Disease Control and Prevention (CDC). National and state vaccination coverage among adolescents aged 13-17 years-United States, 2011. MMWR Morb Mortal Wkly Rep. 2012;61(34):671-677.
12. Javanbakht M, Stahlman S, Walker S, et al. Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community. Vaccine. 2012;30(30):4511-4516.
13. Luque JS, Raychowdhury S, Weaver M. Health care provider challenges for reaching Hispanic immigrants with HPV vaccination in rural Georgia. Rural Remote Health. 2012;12(2):1975.
14. Malo TL, Hassani D, Staras SA, Shenkman EA, Giuliano AR, Vadaparampil ST. Do Florida Medicaid providers' barriers to HPV vaccination vary based on VFC program participation? Matern Child Health J. 2013;17(4):609-615.
15. Meites E, Llata E, Hariri S, et al. HPV vaccine implementation in STD clinics: STD Surveillance Network. Sex Transm Dis. 2012;39(1):32-34.
16. Perkins RB, Clark JA. What affects human papillomavirus vaccination rates? a qualitative analysis of providers' perceptions. Womens Health Issues. 2012;22(4):e379-e386.
17. Perkins RB, Clark JA. Providers' attitudes toward human papillomavirus vaccination in young men: challenges for implementation of 2011 recommendations. Am J Mens Health. 2012;6(4):320-323.
18. Quinn GP, Murphy D, Malo TL, Christie J, Vadaparampil ST. A national survey about human papillomavirus vaccination: what we didn't ask, but physicians wanted us to know. J Pediatr Adolesc Gynecol. 2012;25(4):254-258.
19. Saraiya M, Rosser JI, Cooper CP. Cancers that U.S. physicians believe the HPV vaccine prevents. JWomens Health (Larchmt). 2012;21(2):111-117.
20. Bastani R, Glenn BA, Tsui J, et al. Understanding suboptimal human papillomavirus vaccine uptake among ethnicminority girls. Cancer Epidemiol Biomarkers Prev. 2011;20(7):1463-1472.
21. Dorell C, Yankey D, Strasser S. Parent-reported reasons for nonreceipt of recommended adolescent vaccinations, National Immunization Survey: Teen, 2009. Clin Pediatr (Phila). 2011;50(12):1116-1124.
22. Dorell CG, Yankey D, Santibanez TA, Markowitz LE. Human papillomavirus vaccination series initiation and completion, 2008-2009. Pediatrics. 2011;128(5):830-839.
23. published correction appears in Pediatrics. 2012;130(1):166-168
24. Reynolds D, O'Connell KA. Testing a model for parental acceptance of human papillomavirus vaccine in 9-to 18-year-old girls: a theory-guided study. J Pediatr Nurs. 2012;27(6):614-625.
25. Stokley S, Cohn A, Dorell C, et al. Adolescent vaccination-coverage levels in the United States: 2006-2009. Pediatrics. 2011;128(6):1078-1086.
26. Thompson VL, Arnold LD, Notaro SR. African American parents' attitudes toward HPV vaccination. Ethn Dis. 2011;21(3):335-341.
27. Berenson AB, Rahman M. Gender differences among low income women in their intent to vaccinate their sons and daughters against human papillomavirus infection. J Pediatr Adolesc Gynecol. 2012;25(3):218-220.
28. Dorell C, Yankey D, Kennedy A, Stokley S. Factors that influence parental vaccination decisions for adolescents, 13 to 17 years old: National Immunization Survey-Teen, 2010. Clin Pediatr (Phila). 2013;52(2):162-170.
29. Gilkey MB, Moss JL, McRee AL, Brewer NT. Do correlates of HPV vaccine initiation differ between adolescent boys and girls? Vaccine. 2012;30(41):5928-5934.
30. Griffioen AM, Glynn S, Mullins TK, et al. Perspectives on decision making about human papillomavirus vaccination among 11-to 12-year-old girls and their mothers. Clin Pediatr (Phila). 2012;51(6):560-568.
31. Hoffman L, Okcu MF, Dreyer ZE, Suzawa H, Bryant R, Middleman AB. Human papillomavirus vaccination in female pediatric cancer survivors. J Pediatr Adolesc Gynecol. 2012;25(5):305-307.
32. Joseph NP, Clark JA, Bauchner H, et al. Knowledge, attitudes, and beliefs regarding HPV vaccination: ethnic and cultural differences between African-American and Haitian immigrant women. Womens Health Issues. 2012;22(6):e571-e579.
33. Kepka DL, Ulrich AK, Coronado GD. Low knowledge of the three-dose HPV vaccine series among mothers of rural Hispanic adolescents. J Health Care Poor Underserved. 2012;23(2): 626-635.
34. Kester LM, Zimet GD, Fortenberry JD, Kahn JA, Shew ML. A national study of HPV vaccination of adolescent girls: rates, predictors, and reasons for non-vaccination. Matern Child Health J. 2013;17(5):879-885.
35. Laz TH, Rahman M, Berenson AB. An update on human papillomavirus vaccine uptake among 11-17 year old girls in the United States: National Health Interview Survey, 2010. Vaccine. 2012;30(24):3534-3540.
36. Oldach BR, Katz ML. Ohio Appalachia public health department personnel: human papillomavirus (HPV) vaccine availability, and acceptance and concerns among parents of male and female adolescents. J Community Health. 2012;37(6):1157-1163.
37. Perkins RB, Apte G, Marquez C, et al Factors affecting human papillomavirus vaccine utilization among white, black, and Latino parents of sons. Pediatr Infect Dis J. 2013;32(1):e38-e44.
38. Perkins RB, Brogly SB, Adams WG, Freund KM. Correlates of human papillomavirus vaccination rates in low-income, minority adolescents: a multicenter study. JWomens Health (Larchmt). 2012;21(8):813-820.
39. Sanders Thompson VL, Arnold LD, Notaro SR. African American parents' HPV vaccination intent and concerns. J Health Care Poor Underserved. 2012;23(1):290-301.
40. Tsui J, Gee GC, Rodriguez HP, et al. Exploring the role of neighborhood socio-demographic factors on HPV vaccine initiation among low-income, ethnicminority girls. J Immigr Minor Health. 2013;15(4):732-740.
41. Wilson R, Brown DR, Boothe MA, Harris CE. Knowledge and acceptability of the HPV vaccine among ethnically diverse black women. J Immigr Minor Health. 2013;15(4):747-757.
42. Ylitalo KR, Lee H, Mehta NK. Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey. Am J Public Health. 2012;103(1):164-169.
43. Lechuga J, Swain G, Weinhardt LS. Perceived need of a parental decision aid for the HPV vaccine: content and format preferences. Health Promot Pract. 2012;13(2):214-221.
44. Hamlish T, Clarke L, Alexander KA. Barriers to HPV immunization for African American adolescent females. Vaccine. 2012;30(45):6472-6476.
45. Reimer RA, Houlihan AE, Gerrard M, Deer MM, Lund AJ. Ethnic differences in predictors of HPV vaccination: comparisons of predictors for Latina and non-Latina white women [published online October 2, 2012]. J Sex Res. doi:10.1080/00224499.2012.692406.
46. Dempsey AF, Butchart A, Singer D, Clark S, Davis M. Factors associated with parental intentions for male human papillomavirus vaccination: results of a national survey. Sex Transm Dis. 2011;38(8):769-776.
47. Gutierrez B Jr, Leung A, Jones KT, et al. Acceptability of the human papillomavirus vaccine among urban adolescent males. AmJ Mens Health. 2013;7(1):27-36.
48. Schluterman NH, Terplan M, Lydecker AD, Tracy JK. Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital. Vaccine. 2011;29(21):3767-3772.
49. Tan W, Viera AJ, Rowe-West B, Grimshaw A, Quinn B, Walter EB. The HPV vaccine: are dosing recommendations being followed? Vaccine. 2011;29(14):2548-2554.
50. Rubin RF, Kuttab HM, Rihani RS, Reutzel TJ. Patient adherence to three dose completion of the quadrivalent human papillomavirus (HPV) vaccine in a private practice. J Community Health. 2012;37(6):1145-1150.
51. Goff SL, Mazor KM, Gagne SJ, Corey KC, Blake DR. Vaccine counseling: a content analysis of patient-physician discussions regarding human papilloma virus vaccine. Vaccine. 2011;29(43):7343-7349.
52. Hughes CC, Jones AL, Feemster KA, Fiks AG. HPV vaccine decision making in pediatric primary care: a semi-structured interview study. BMC Pediatr. 2011;11:74.
53. Centers for Disease Control and Prevention (CDC). National, state, and local area vaccination coverage among adolescents aged 13-17 years-United States, 2009. MMWR Morb Mortal Wkly Rep. 2010;59(32):1018-1023.
54. Freed GL, Clark SJ, Butchart AT, Singer DC, Davis MM. Parental vaccine safety concerns in 2009. Pediatrics. 2010;125(4):654-659.
55. Litton AG, Desmond RA, Gilliland J, Huh WK, Franklin FA. Factors associated with intention to vaccinate a daughter against HPV: a statewide survey in Alabama. J Pediatr Adolesc Gynecol. 2011;24(3):166-171.
56. Baldwin AS, Bruce CM, Tiro JA. Understanding how mothers of adolescent girls obtain information about the HPV vaccine. J Health Psychol. 2013;18(7):926-938.
57. Moss JL, Gilkey MB, Reiter PL, Brewer NT. Trends in HPV vaccine initiation among adolescent females in North Carolina, 2008-2010. Cancer Epidemiol Biomarkers Prev. 2012;21(11):1913-1922.
58. Thomas TL, Strickland OL, DiClemente R, Higgins M, Haber M. Rural African American parents' knowledge and decisions about human papillomavirus vaccination. J Nurs Scholarsh. 2012;44(4):358-367.
59. Tiro JA, Pruitt SL, Bruce CM, et al. Multilevel correlates for human papillomavirus vaccination of adolescent girls attending safety net clinics. Vaccine. 2012;30(13):2368-2375.
60. Lechuga J, Swain GR, Weinhardt LS. The cross-cultural variation of predictors of human papillomavirus vaccination intentions. JWomens Health (Larchmt). 2011;20(2):225-230.
61. Henderson CE, Rich JD, Lally MA. HPV vaccination practices among juvenile justice facilities in the United States. J Adolesc Health. 2010;46(5):495-498.
62. Reiter PL, McRee AL, Gottlieb SL, Brewer NT. HPV vaccine for adolescent males: acceptability to parents post-vaccine licensure. Vaccine. 2010;28(38):6292-6297.
63. Reiter PL, McRee AL, Kadis JA, Brewer NT. HPV vaccine and adolescent males. Vaccine. 2011;29(34):5595-5602.
64. Kouyoumdjian FG, Bailowitz A. Completion of the human papillomavirus vaccine series in females attending an urban immunization clinic. Pediatr Infect Dis J. 2011;30(8):718-719.
65. Widdice LE, Bernstein DI, Leonard AC, Marsolo KA, Kahn JA. Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics. 2011;127(1):77-84.
66. Hirth JM, Tan A, Wilkinson GS, Berenson AB. Completion of the human papillomavirus vaccine series among insured females between 2006 and 2009. Cancer. 2012;118(22):5623-5629.
67. Dempsey A, Cohn L, Dalton V, Ruffin M. Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system. Vaccine. 2010;28(4):989-995.
68. Gowda C, Dempsey AF. Medicaid reimbursement and the uptake of adolescent vaccines. Vaccine. 2012;30(9):1682-1689.
69. Mollborn S, Everett B. Correlates and consequences of parent-teen incongruence in reports of teens' sexual experience. J Sex Res. 2010;47(4):314-329.
70. Block SL, Nolan T, Sattler C, et al; Protocol 016 Study Group. Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women. Pediatrics. 2006;118(5):2135-2145. (Pubitemid 46393698)
71. Watson M, Saraiya M, Benard V, et al. Burden of cervical cancer in the United States, 1998-2003. Cancer. 2008;113(10)(suppl):2855-2864.
72. Rand CM, Szilagyi PG, Albertin C, Auinger P. Additional health care visits needed among adolescents for human papillomavirus vaccine delivery within medical homes: a national study. Pediatrics. 2007;120(3):461-466. (Pubitemid 47358286)
73. Woodwell DA, Cherry DK. National Ambulatory Medical Care Survey: 2002 summary. Adv Data. 2004;(346):1-44.
74. Humiston SG, Rosenthal SL. Challenges to vaccinating adolescents: vaccine implementation issues. Pediatr Infect Dis J. 2005;24(6)(suppl):S134-S140. (Pubitemid 40840110)
75. Suh CA, Saville A, Daley MF, et al. Effectiveness and net cost of reminder/recall for adolescent immunizations. Pediatrics. 2012;129(6):e1437- e1445.
76. Kontos EZ, Emmons KM, Puleo E, Viswanath K. Contribution of communication inequalities to disparities in human papillomavirus vaccine awareness and knowledge. Am J Public Health. 2012;102(10):1911-1920.
77. Edwards SM, Rousseau-Pierre T. Immunizations in adolescents: an update. Adolesc Med State Art Rev. 2010;21(2):173-186, vii.
78. Farrell RM, Rome ES. Adolescents' access and consent to the human papillomavirus vaccine. Pediatrics. 2007;120(2):434-437.
79. Hershey JH, Velez LF. Public health issues related to HPV vaccination. J Public Health Manag Pract. 2009;15(5):384-392.
80. Vetter KM, Geller SE. Moving forward: human papillomavirus vaccination and the prevention of cervical cancer. JWomens Health (Larchmt). 2007;16(9):1258-1268. (Pubitemid 350125868)
81. Fisher JW, Brundage SI. The challenge of eliminating cervical cancer in the United States. Women Health. 2009;49(2-3):246-261.
82. Lehmann C, Benson PA. Vaccine adherence in adolescents. Clin Pediatr (Phila). 2009;48(8): 801-811.
83. McRee AL, Brewer NT, Reiter PL, Gottlieb SL, Smith JS. The Carolina HPV immunization attitudes and beliefs scale (CHIAS): scale development and associations with intentions to vaccinate. Sex Transm Dis. 2010;37(4):234-239.
84. Frieden TR. A framework for public health action: the health impact pyramid. Am J Public Health. 2010;100(4):590-595.